These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4529310)

  • 1. Maximum likelihood solutions for the combination of relative potencies.
    Armitage P; Bennett BM
    J Hyg (Lond); 1974 Aug; 73(1):97-9. PubMed ID: 4529310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate bioassay.
    Vølund A
    Biometrics; 1980 Jun; 36(2):225-36. PubMed ID: 6996751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point and interval estimation in the combination of bioassay results.
    Armitage P; Bennett BM; Finney DJ
    J Hyg (Lond); 1976 Feb; 76(1):147-62. PubMed ID: 1060692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model-free approach to estimation of relative potency in dose-response curve analysis.
    Guardabasso V; Rodbard D; Munson PJ
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E357-64. PubMed ID: 3826362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
    Louisse J; Gönen S; Rietjens IM; Verwei M
    Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative potencies of thiopentone and propofol.
    Grounds RM; Moore M; Morgan M
    Eur J Anaesthesiol; 1986 Jan; 3(1):11-7. PubMed ID: 3490970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of cancer drug potencies and relative potencies from in vitro data.
    Le Chap T; Grambsch PM; Liu A
    J Biopharm Stat; 2005; 15(6):903-12. PubMed ID: 16279350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Truth in packaging?' The unwrapping of epidemiologic research.
    Lanes SF; Poole C
    J Occup Med; 1984 Aug; 26(8):571-4. PubMed ID: 6481496
    [No Abstract]   [Full Text] [Related]  

  • 9. Statistical methodologies of dose-response relationship in epidemiology.
    Park CB
    J UOEH; 1983 Mar; 5 Suppl():175-82. PubMed ID: 6679668
    [No Abstract]   [Full Text] [Related]  

  • 10. Maximum likelihood applied to a capture-recapture model.
    Sprott DA
    Biometrics; 1981 Jun; 37(2):371-5. PubMed ID: 7272420
    [No Abstract]   [Full Text] [Related]  

  • 11. Methods: statistics and epidemiology technology and science.
    Schneiderman M
    Arch Environ Health; 1988; 43(2):133-7. PubMed ID: 3377547
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiologic programs for computers and calculators. A microcomputer program for multiple logistic regression by unconditional and conditional maximum likelihood methods.
    Campos-Filho N; Franco EL
    Am J Epidemiol; 1989 Feb; 129(2):439-44. PubMed ID: 2912052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estimation of relative potency from two parabolas in symmetric bioassays.
    Williams DA
    Biometrics; 1973 Dec; 29(4):695-700. PubMed ID: 4785234
    [No Abstract]   [Full Text] [Related]  

  • 14. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-parametric interval estimation of relative potency for dilution assays, including the case of non-monotone dosage response curves.
    Mantel N; Schneiderman MA
    Biometrics; 1975 Sep; 31(3):619-32. PubMed ID: 1174621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exact confidence region for a relative potency estimated from combined bioassays.
    Williams DA
    Biometrics; 1978 Dec; 34(4):659-61. PubMed ID: 749948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined maximum likelihood estimates for the equicorrelation coefficient.
    Viana MA
    Biometrics; 1994 Sep; 50(3):813-20. PubMed ID: 7981400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of low-dose carcinogenicity.
    Armitage P
    Biometrics; 1982 Mar; 38 Suppl():119-39. PubMed ID: 7046818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic microplate bioassays for relative potency of antibiotics improved by partial Least Square (PLS) regression.
    Francisco FL; Saviano AM; Almeida Tde S; Lourenço FR
    J Microbiol Methods; 2016 May; 124():28-34. PubMed ID: 26971814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific bases for identification of potential carcinogens and estimation of risks. Interagency Regulatory Liaison Group, Work Group on Risk Assessment.
    Annu Rev Public Health; 1980; 1():345-93. PubMed ID: 6753864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.